IN Vitro Diagnostic Test for Basal-Like Breast Cancer - A molecular diagnostic test based on detection of transcription factor FOXC1 at the protein and RNA level will be developed to accurately diagnose basal-like breast cancer (BLBC).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research – Phase II (N44)
Project #
261201300028C-0-0-1
Application #
8762468
Study Section
Project Start
2013-09-18
Project End
2015-09-17
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$995,819
Indirect Cost
Name
Oracle Biosciences, LLC
Department
Type
DUNS #
968727375
City
Urbana
State
IL
Country
United States
Zip Code
61801